Abiopharma

Nautilus Biotechnology to Participate in Upcoming September Investor Conferences

Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference

Alnylam to Webcast Presentations at Upcoming September Investor Conferences

Belite Bio to Participate in Three Upcoming Investor Conferences

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences

Annexon Biosciences to Participate in Upcoming September Investor Conferences

enGene to Participate in Upcoming Investor Conferences

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

Director Honigblum Gregg R. 🟢 acquired 50.0K shares of Sintx Technologies, Inc. (SINT) at $3.75 Transaction Date: Aug 26, 2025 | Filing ID: 012366

Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025

UPDATE -- BioXcel Therapeutics Announces SERENITY At-Home Pivotal Phase 3 Safety Trial Met its Primary Endpoint in Support of sNDA Submission for Label Expansion of IGALMI®

Aclaris Therapeutics to Participate in Two September Healthcare Conferences

Evaxion to present at several conferences during the second half of 2025

Greenway Announces First Quarter Financial Statements

New Form 424B5 - Vor Biopharma Inc. Filed: 2025-08-27 AccNo: 0001193125-25-189133 Size: 533 KB